Allient Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; balance-sheet comparisons are against December 31, 2023. Allient designs and manufactures precision motion, control, power and related products for industrial, vehicle, medical, and aerospace and defense markets. Unless noted otherwise, financial amounts below are in millions of dollars.
Financial results and comparison with Q1 2023
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $146.7 | $145.5 | +0.8% |
| Gross profit / margin | $47.4 / 32.3% | $45.8 / 31.5% | Profit +3%; margin +0.8 percentage points |
| Operating income | $12.1 | $11.4 | +6% |
| Interest expense | $3.4 | $3.0 | +14% |
| Net income | $6.9 | $6.3 | +9% |
| Diluted EPS | $0.42 | $0.39 | +7% |
| Operating cash flow | $9.2 | $3.6 | +$5.6 |
| Bookings / backlog | $122.1 / $258.1 | $123.2 / $308.6 | Bookings −1%; backlog −16% |
Reported revenue was supported by acquisitions: management cited $9.5 million of incremental revenue from acquisitions, while organic revenue declined 5.9%. Industrial and vehicle revenue increased; medical and aerospace and defense revenue declined. Gross-margin improvement reflected higher volume and cost absorption, pricing, and favorable mix. Higher interest rates and debt-issuance-cost amortization contributed to increased interest expense.
Management also reported non-GAAP adjusted EBITDA of $20.0 million versus $19.0 million, and adjusted net income of $9.5 million versus $8.9 million. These are non-GAAP measures and are not substitutes for GAAP results.
Cash, liquidity, debt, and capital allocation
- Cash and cash equivalents were $31.5 million at March 31, 2024, down $0.4 million from year-end; $21.1 million was held at foreign subsidiaries and may incur withholding tax if repatriated.
- Operating cash flow was $9.2 million. Investing used $28.5 million, including $20 million paid in cash for SNC and $3.0 million of capital expenditures. Financing provided $19.5 million; cash ended the quarter at $31.5 million.
- Balance-sheet long-term debt was $240.2 million, including finance lease obligations and net of unamortized debt issuance costs. Separately, the company reported $184.0 million outstanding on its revolving facility and $50.0 million of senior notes; $96.0 million of revolving capacity was unused, subject to covenant and borrowing limitations.
- Allient amended its revolving facility to $280 million, extended maturity to March 1, 2029, and established a $150 million private shelf facility. It issued $50 million of 5.96% fixed-rate notes due March 21, 2031. The company said it was in compliance with debt covenants at quarter-end.
- Current assets were $260.0 million and current liabilities $73.1 million. Inventories increased to $124.9 million from $117.7 million at year-end.
- The quarterly dividend was $0.03 per share, up from $0.025 in Q1 2023. Shares outstanding were 16.9 million at quarter-end.
Acquisitions, outlook, and management commentary
- Allient acquired SNC Manufacturing and Acutran de Mexico on January 11, 2024, for an initial $20.0 million cash payment, subject to customary adjustments. SNC contributed $8.5 million in Q1 revenue and $0.7 million in net income. Purchase accounting remains preliminary.
- Management’s “Simplify to Accelerate” strategy focuses on realigning and right-sizing the company’s footprint, strengthening lean manufacturing and margins, and reducing working capital to generate cash and deleverage.
- Management expects a 2024 effective tax rate of approximately 21%–23% and full-year capital expenditures of $13 million–$17 million. No full-year revenue or earnings guidance is provided in the filing.
- Management said cash, expected operating cash flows, and available financing should be sufficient for ordinary-course needs over the next 12 months. It noted persistent inflation, elevated interest rates, geopolitical uncertainty, supply-chain and labor pressures, changing customer order patterns, and larger inventory needs.
- Foreign currency translation reduced comprehensive income by $4.4 million in Q1, compared with a $1.4 million gain in Q1 2023. One customer represented 12% of Q1 revenue.
Risks, controls, and contingencies
The filing identifies risks including economic and geopolitical uncertainty, foreign-exchange and interest-rate exposure, customer demand and backlog conversion, supplier availability, cybersecurity and IT disruption, competition, talent retention, and acquisition integration. The company uses currency contracts and interest-rate swaps; $100 million of revolving debt was hedged at quarter-end, and management estimated that a 100-basis-point change in rates on the unhedged balance would affect quarterly interest expense by about $0.3 million. The filing reports no material change to the risk factors in the 2023 Form 10-K, no material change in internal control over financial reporting, and effective disclosure controls. Commitments and contingencies are described in the filing; no specific material litigation outcome is stated in the provided text.
Important facts for investors to verify
- Whether organic demand stabilizes: reported revenue growth included acquisition contributions, while organic revenue fell 5.9% and backlog declined 16% year over year.
- Whether the improved gross margin and operating cash flow are sustained, particularly as inventory rose and management pursues working-capital reductions.
- Debt and covenant headroom after acquisitions, including the impact of leverage limits on access to stated unused revolving capacity.
- Integration and performance of SNC and prior acquisitions, including final purchase-price adjustments and realization of expected synergies.
- Exposure to foreign exchange, interest rates, customer concentration, and changing aerospace and defense, medical, and industrial order patterns.